These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 11438639)

  • 21. The role of radioactive iodine in the treatment of well-differentiated thyroid cancer.
    Weigel RJ; McDougall IR
    Surg Oncol Clin N Am; 2006 Jul; 15(3):625-38. PubMed ID: 16882501
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Postoperative uptake in the thyroid bed, not tumor stage, determines the usefulness of diagnostic whole body scan in the first year after ablation with radioiodine.
    Rosário PW; Barroso AL; Purisch S
    Thyroid; 2007 Aug; 17(8):803-4. PubMed ID: 17708716
    [No Abstract]   [Full Text] [Related]  

  • 23. Artifactual I-131 activity in the hairs after thyroid remnant ablation.
    Bhargava P; Choi WS
    Thyroid; 2006 Nov; 16(11):1187-9. PubMed ID: 17123350
    [No Abstract]   [Full Text] [Related]  

  • 24. Radioiodine uptake in thyroid remnants during therapy after tracer dosimetry.
    Yeung HW; Humm JL; Larson SM
    J Nucl Med; 2000 Jun; 41(6):1082-5. PubMed ID: 10855639
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic risk assessment after iodine-131 exposure: an opportunity and obligation for nuclear medicine.
    Dottorini ME
    J Nucl Med; 1996 Apr; 37(4):612-5. PubMed ID: 8691250
    [No Abstract]   [Full Text] [Related]  

  • 26. Impact of 131I diagnostic activities on the biokinetics of thyroid remnants.
    Lassmann M; Luster M; Hänscheid H; Reiners C
    J Nucl Med; 2004 Apr; 45(4):619-25. PubMed ID: 15073258
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Radioiodine treatment of differentiated thyroid carcinomas: residual ablation].
    Konrády A
    Orv Hetil; 2002 Jun; 143(25):1557; author reply. PubMed ID: 12577410
    [No Abstract]   [Full Text] [Related]  

  • 28. Blood and bone marrow dosimetry in radioiodine therapy of thyroid cancer.
    Sgouros G
    J Nucl Med; 2005 May; 46(5):899-900; author reply 901. PubMed ID: 15872367
    [No Abstract]   [Full Text] [Related]  

  • 29. Radioactive iodine in thyroid medicine--how it started in Sweden and some of today's challenges.
    Mattsson S; Johansson L; Jönsson H; Nosslin B
    Acta Oncol; 2006; 45(8):1031-6. PubMed ID: 17118834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blood and bone marrow dosimetry in radioiodine therapy of differentiated thyroid cancer after stimulation with rhTSH.
    Lassmann M; Hänscheid H; Reiners C; Thomas SR
    J Nucl Med; 2005 May; 46(5):900-1; author reply 901. PubMed ID: 15872369
    [No Abstract]   [Full Text] [Related]  

  • 31. Blood dosimetry and dose-rate effects after radioiodine therapy of differentiated thyroid cancer.
    Lassmann M; Luster M; Hänscheid H; Reiners C
    J Nucl Med; 2005 May; 46(5):899. PubMed ID: 15872368
    [No Abstract]   [Full Text] [Related]  

  • 32. Thyroid stunning in clinical practice: is it a real problem?
    Filesi M; Colandrea M; Montesano T; D'Apollo R; Ronga G
    Minerva Endocrinol; 2009 Mar; 34(1):29-36. PubMed ID: 19209126
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Re: the so-called stunning of thyroid tissue.
    Hilditch TE; Bolster AA; Dempsey MF; Reed NS
    J Nucl Med; 2007 Apr; 48(4):675-6; author reply 676. PubMed ID: 17401107
    [No Abstract]   [Full Text] [Related]  

  • 34. Exercise-induced radio-iodine accumulation in scalp and hair during admission of 131I therapy for thyroid cancer.
    Zakavi SR; Kakhki VD
    Thyroid; 2006 Nov; 16(11):1185-6. PubMed ID: 17123349
    [No Abstract]   [Full Text] [Related]  

  • 35. Radioiodine in treatment of metastatic thyroid cancer.
    Dewan SS; Sharma SM; Ganatra RD
    Int J Nucl Med Biol; 1979; 6(4):213-4. PubMed ID: 528148
    [No Abstract]   [Full Text] [Related]  

  • 36. A case of stunning of lung and bone metastases of papillary thyroid cancer after a therapeutic dose (3.7 GBq) of 131I and review of the literature: implications for sequential treatments.
    Leger AF; Pellan M; Dagousset F; Chevalier A; Keller I; Clerc J
    Br J Radiol; 2005 May; 78(929):428-32. PubMed ID: 15845937
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Percent 131I uptake and post-therapy 131I scans: their role in the management of thyroid cancer.
    Reynolds JC
    Thyroid; 1997 Apr; 7(2):281-4. PubMed ID: 9133701
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stunned thyroid after a diagnostic dose of I-131 for a whole body scan.
    Kao CH
    Clin Nucl Med; 1998 Feb; 23(2):102-4. PubMed ID: 9481500
    [No Abstract]   [Full Text] [Related]  

  • 39. I-131 uptake demonstrated in the appendix on a posttreatment scan in a patient with thyroid cancer.
    Borkar S; Grewal R; Schoder H
    Clin Nucl Med; 2008 Aug; 33(8):551-2. PubMed ID: 18645376
    [No Abstract]   [Full Text] [Related]  

  • 40. Esophageal diverticulum presenting as metastatic thyroid mass on iodine-131 scintigraphy.
    Rashid K; Johns W; Chasse K; Walker M; Gupta SM
    Clin Nucl Med; 2006 Jul; 31(7):405-8. PubMed ID: 16785810
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.